Title | Type | SJR | H index | Total Docs. (2023) | Total Docs. (3years) | Total Refs. (2023) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2023) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
172 | NTP Immunotoxicity Technical Report Series | book series | 0.133 Q4 | 0 | 0 | 3 | 0 | 0 | 1 | 0.00 | 0.00 | |
171 | Journal of Caffeine and Adenosine Research | journal | 0.112 Q4 | 1 | 0 | 8 | 0 | 1 | 5 | 0.13 | 0.00 | |
170 | NTP Developmental and Reproductive Toxicity Technical Report Series | book series | 0.111 Q4 | 1 | 0 | 11 | 0 | 0 | 3 | 0.00 | 0.00 | |
169 | NTP Research Report Series | book series | 0.117 Q4 | 3 | 1 | 4 | 21 | 1 | 4 | 0.00 | 21.00 | |
168 | Cancer Innovation | journal | 0.389 Q2 | 4 | 56 | 20 | 3056 | 23 | 19 | 1.15 | 54.57 | |
167 | WikiJournal of Medicine | journal | 0.134 Q4 | 4 | 5 | 14 | 385 | 9 | 14 | 0.50 | 77.00 | |
166 | NTP Technical Report on the Toxicity Studies Series | book series | 0.110 Q4 | 6 | 2 | 10 | 191 | 2 | 9 | 0.14 | 95.50 | |
165 | Precision Nanomedicine | journal | 0.219 Q3 | 6 | 14 | 43 | 1070 | 42 | 41 | 1.13 | 76.43 | |
164 | Pharmaceutical Outsourcing | journal | 0.103 Q4 | 7 | 0 | 15 | 0 | 0 | 12 | 0.00 | 0.00 | |
163 | Adverse Drug Reaction Bulletin | journal | 0.126 Q4 | 8 | 6 | 18 | 196 | 5 | 18 | 0.17 | 32.67 | |
162 | Drug Topics | journal | 0.104 Q4 | 8 | 104 | 412 | 180 | 2 | 71 | 0.01 | 1.73 | |
161 | Pharmacy Times | trade journal | 0.100 Q4 | 8 | 62 | 341 | 387 | 1 | 233 | 0.00 | 6.24 | |
160 | NTP Technical Report on the Toxicology and Carcinogenesis Studies Series | book series | 0.111 Q4 | 9 | 2 | 3 | 348 | 0 | 3 | 0.00 | 174.00 | |
159 | ACS Bio and Med Chem Au | journal | 1.036 Q1 | 11 | 48 | 62 | 3007 | 245 | 58 | 3.95 | 62.65 | |
158 | Drug Development and Delivery | trade journal | 0.104 Q4 | 12 | 79 | 198 | 606 | 5 | 89 | 0.02 | 7.67 | |
157 | U.S. Pharmacist | trade journal | 0.128 Q4 | 12 | 126 | 375 | 1108 | 65 | 247 | 0.18 | 8.79 | |
156 | International Journal of Pharmaceutical Compounding | journal | 0.130 Q4 | 13 | 10 | 204 | 0 | 53 | 195 | 0.26 | 0.00 | |
155 | Applied In Vitro Toxicology | journal | 0.321 Q3 | 15 | 16 | 48 | 582 | 67 | 39 | 1.53 | 36.38 | |
154 | Journal of Pharmacy Technology | journal | 0.330 Q3 | 16 | 52 | 133 | 1092 | 149 | 118 | 1.07 | 21.00 | |
153 | Journal of Excipients and Food Chemicals | journal | 0.128 Q4 | 17 | 10 | 30 | 330 | 10 | 19 | 0.41 | 33.00 | |
152 | Current Protocols | journal | 1.520 Q1 | 18 | 299 | 579 | 11528 | 1993 | 576 | 3.44 | 38.56 | |
151 | JACCP Journal of the American College of Clinical Pharmacy | journal | 0.433 Q2 | 19 | 167 | 497 | 5047 | 643 | 412 | 1.09 | 30.22 | |
150 | Pharmaceutical Technology Europe | journal | 0.111 Q4 | 19 | 127 | 287 | 630 | 8 | 227 | 0.03 | 4.96 | |
149 | OpenNano | journal | 0.824 Q1 | 21 | 80 | 73 | 7983 | 473 | 73 | 6.48 | 99.79 | |
148 | Medical Letter on Drugs and Therapeutics | journal | 0.239 Q3 | 22 | 149 | 346 | 932 | 168 | 239 | 0.49 | 6.26 | |
147 | National Toxicology Program technical report series | journal | 0.111 Q4 | 22 | 2 | 5 | 185 | 1 | 5 | 0.00 | 92.50 | |
146 | Neuropsychopharmacology Reports | journal | 0.660 Q2 | 22 | 105 | 201 | 3867 | 480 | 199 | 2.40 | 36.83 | |
145 | Food and Drug Law Journal | journal | 0.145 Q4 | 23 | 12 | 14 | 1814 | 4 | 14 | 0.29 | 151.17 | |
144 | Mental Health Clinician | journal | 0.356 Q2 | 23 | 8 | 89 | 238 | 105 | 89 | 1.24 | 29.75 | |
143 | MedComm | journal | 1.926 Q1 | 25 | 223 | 171 | 32320 | 1408 | 145 | 9.20 | 144.93 | |
142 | American Pharmaceutical Review | journal | 0.103 Q4 | 26 | 0 | 29 | 0 | 4 | 27 | 0.00 | 0.00 | |
141 | Contemporary Clinical Trials Communications | journal | 0.636 Q2 | 26 | 176 | 511 | 7402 | 849 | 507 | 1.52 | 42.06 | |
140 | International Nano Letters | journal | 0.586 Q2 | 26 | 20 | 90 | 1419 | 441 | 90 | 5.05 | 70.95 | |
139 | Bioengineering and Translational Medicine | journal | 1.655 Q1 | 28 | 258 | 178 | 19950 | 1422 | 167 | 7.79 | 77.33 | |
138 | Hospital Pharmacy | journal | 0.308 Q3 | 28 | 110 | 307 | 2615 | 286 | 273 | 0.90 | 23.77 | |
137 | Molecular and Cellular Pharmacology | journal | 0.133 Q4 | 28 | 3 | 5 | 15 | 0 | 1 | 0.00 | 5.00 | |
136 | Value in Health Regional Issues | journal | 0.525 Q1 | 28 | 89 | 268 | 3569 | 416 | 254 | 1.48 | 40.10 | |
135 | Profiles of Drug Substances, Excipients and Related Methodology | journal | 0.688 Q2 | 29 | 7 | 21 | 562 | 185 | 7 | 10.64 | 80.29 | |
134 | Current protocols in toxicology / editorial board, Mahin D. Maines (editor-in-chief) ... [et al.] | journal | 0.115 Q4 | 31 | 0 | 10 | 0 | 4 | 10 | 0.00 | 0.00 | |
133 | Currents in Pharmacy Teaching and Learning | journal | 0.450 Q2 | 31 | 148 | 656 | 3196 | 778 | 600 | 1.01 | 21.59 | |
132 | BioPharm International | trade journal | 0.106 Q4 | 32 | 112 | 274 | 423 | 17 | 89 | 0.06 | 3.78 | |
131 | Current Cardiovascular Risk Reports | journal | 0.491 Q3 | 34 | 21 | 72 | 1537 | 119 | 72 | 1.94 | 73.19 | |
130 | Journal of Herbs, Spices and Medicinal Plants | journal | 0.255 Q3 | 34 | 32 | 88 | 1098 | 151 | 88 | 1.45 | 34.31 | |
129 | Clinical Pharmacology in Drug Development | journal | 0.626 Q2 | 35 | 140 | 398 | 3021 | 753 | 385 | 1.86 | 21.58 | |
128 | Journal of Pharmaceutical Innovation | journal | 0.386 Q2 | 35 | 179 | 248 | 7638 | 625 | 234 | 2.49 | 42.67 | |
127 | ACS Pharmacology and Translational Science | journal | 1.286 Q1 | 36 | 151 | 419 | 10553 | 2104 | 399 | 5.21 | 69.89 | |
126 | Cancer Nanotechnology | journal | 0.671 Q2 | 36 | 83 | 90 | 4754 | 399 | 89 | 4.21 | 57.28 | |
125 | Dissolution Technologies | journal | 0.218 Q3 | 36 | 27 | 69 | 806 | 61 | 65 | 0.90 | 29.85 | |
124 | Current Protocols in Pharmacology | journal | 0.670 Q2 | 39 | 0 | 11 | 0 | 30 | 11 | 0.00 | 0.00 | |
123 | Pharmaceutical Chemistry Journal | journal | 0.195 Q4 | 39 | 252 | 683 | 7999 | 578 | 682 | 0.79 | 31.74 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®